speb/financial-data huggingface dataset:
ORGN cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -1712000.00
ORGN cash_flow (annual, 2024-12-31) — Change In Payable: 373000.00
ORGN cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -3217000.00
ORGN cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 2397000.00
ORGN cash_flow (annual, 2024-12-31) — Change In Receivables: -3359000.00
ORGN cash_flow (annual, 2024-12-31) — Change In Working Capital: -10595000.00
ORGN cash_flow (annual, 2024-12-31) — Changes In Cash: -18715000.00
ORGN balance_sheet (annual, 2024-12-31) — Common Stock: 15000.00
ORGN balance_sheet (annual, 2024-12-31) — Common Stock Equity: 338365000.00
ORGN balance_sheet (annual, 2024-12-31) — Construction In Progress: 40331000.00
ORGN income_statement (annual, 2024-12-31) — Cost Of Revenue: 30864000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2779000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Assets: 139174000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 323000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Debt: 3772000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 4095000.00
ORGN balance_sheet (annual, 2024-12-31) — Current Liabilities: 12549000.00
ORGN cash_flow (annual, 2024-12-31) — Deferred Income Tax: 640000.00
ORGN cash_flow (annual, 2024-12-31) — Deferred Tax: 640000.00
ORGN cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 10715000.00
ORGN income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 10715000.00
ORGN cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 10715000.00
ORGN income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 10715000.00
ORGN balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 4566000.00
ORGN income_statement (annual, 2024-12-31) — Diluted Average Shares: 4773087.00
ORGN income_statement (annual, 2024-12-31) — Diluted EPS: -17.40
ORGN income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -83697000.00
ORGN income_statement (annual, 2024-12-31) — EBIT: -82657000.00
ORGN income_statement (annual, 2024-12-31) — EBITDA: -71942000.00
ORGN cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -480000.00
ORGN cash_flow (annual, 2024-12-31) — End Cash Position: 56307000.00
ORGN cash_flow (annual, 2024-12-31) — Financing Cash Flow: 3556000.00
ORGN balance_sheet (annual, 2024-12-31) — Finished Goods: 827000.00
ORGN balance_sheet (quarterly, 2024-12-31) — Finished Goods: 827000.00
ORGN cash_flow (annual, 2024-12-31) — Free Cash Flow: -59783000.00
ORGN cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 3881000.00
ORGN income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 3848000.00
ORGN balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -16709000.00
ORGN income_statement (annual, 2024-12-31) — General And Administrative Expense: 40766000.00
ORGN balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 73000.00
ORGN balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 20409000.00
ORGN balance_sheet (annual, 2024-12-31) — Gross PPE: 224986000.00
ORGN income_statement (annual, 2024-12-31) — Gross Profit: 418000.00
ORGN cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 23000.00
ORGN cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 0.00
ORGN income_statement (annual, 2024-12-31) — Interest Expense: 371000.00
ORGN income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 371000.00
ORGN cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 1708000.00
ORGN balance_sheet (annual, 2024-12-31) — Inventory: 866000.00
ORGN balance_sheet (annual, 2024-12-31) — Invested Capital: 343867000.00
ORGN cash_flow (annual, 2024-12-31) — Investing Cash Flow: 28559000.00
ORGN cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
ORGN balance_sheet (annual, 2024-12-31) — Land And Improvements: 58508000.00
ORGN balance_sheet (annual, 2024-12-31) — Leases: 4765000.00
ORGN balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 3858000.00
ORGN balance_sheet (annual, 2024-12-31) — Long Term Debt: 1730000.00
ORGN balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 1730000.00
ORGN balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 5588000.00
ORGN cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
ORGN cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -4793000.00
ORGN balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 114151000.00
ORGN income_statement (annual, 2024-12-31) — Net Income: -83697000.00
ORGN income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -83697000.00
ORGN income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -83697000.00
ORGN income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -83697000.00
ORGN income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -83697000.00
ORGN cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -83697000.00
ORGN income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -83697000.00
ORGN cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
ORGN income_statement (annual, 2024-12-31) — Net Interest Income: -371000.00
ORGN cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 37512000.00
ORGN cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -4793000.00
ORGN cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -4793000.00
ORGN income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -371000.00
ORGN cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 8097000.00
ORGN cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: 0.00
ORGN balance_sheet (annual, 2024-12-31) — Net PPE: 207654000.00
ORGN cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -8953000.00
ORGN balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 338292000.00
ORGN balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 621000.00
ORGN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 621000.00
ORGN balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 621000.00
ORGN balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 621000.00
ORGN income_statement (annual, 2024-12-31) — Normalized EBITDA: -59841000.00
ORGN income_statement (annual, 2024-12-31) — Normalized Income: -74137210.00
ORGN cash_flow (annual, 2024-12-31) — Operating Cash Flow: -50830000.00
ORGN cash_flow (annual, 2024-12-31) — Operating Gains Losses: 3881000.00
ORGN income_statement (annual, 2024-12-31) — Operating Income: -69617000.00
ORGN income_statement (annual, 2024-12-31) — Operating Revenue: 31282000.00
ORGN balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4952474.00
ORGN balance_sheet (annual, 2024-12-31) — Other Current Assets: 2401000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 3772000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 2754000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -16709000.00
ORGN income_statement (annual, 2024-12-31) — Other Gand A: 40766000.00
ORGN income_statement (annual, 2024-12-31) — Other Income Expense: -13040000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 73000.00
ORGN cash_flow (annual, 2024-12-31) — Other Non Cash Items: 1221000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 30505000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 16959000.00
ORGN income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -939000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Properties: 7231000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Receivables: 2526000.00
ORGN balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 46613000.00
ORGN balance_sheet (annual, 2024-12-31) — Payables: 2921000.00
ORGN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5700000.00
ORGN balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
ORGN income_statement (annual, 2024-12-31) — Pretax Income: -83028000.00
ORGN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 252000.00
ORGN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 7000.00
ORGN balance_sheet (annual, 2024-12-31) — Properties: 0.00
ORGN cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 1869000.00
ORGN cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
ORGN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -1817317000.00
ORGN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -8953000.00
ORGN balance_sheet (annual, 2024-12-31) — Raw Materials: 39000.00
ORGN balance_sheet (annual, 2024-12-31) — Receivables: 21705000.00
ORGN income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 30864000.00
ORGN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 10715000.00
ORGN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -4793000.00
ORGN income_statement (annual, 2024-12-31) — Research And Development: 18554000.00
ORGN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 703000.00
ORGN income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: -1698000.00
ORGN balance_sheet (annual, 2024-12-31) — Retained Earnings: -38127000.00
ORGN cash_flow (annual, 2024-12-31) — Sale Of Investment: 1854829000.00
ORGN cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
ORGN income_statement (annual, 2024-12-31) — Selling General And Administration: 40766000.00
ORGN balance_sheet (annual, 2024-12-31) — Share Issued: 4952474.00
ORGN income_statement (annual, 2024-12-31) — Special Income Charges: -15949000.00
ORGN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 10080000.00
ORGN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 338365000.00
ORGN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 338292000.00
ORGN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -2541210.00
ORGN income_statement (annual, 2024-12-31) — Tax Provision: 669000.00
ORGN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
ORGN balance_sheet (annual, 2024-12-31) — Total Assets: 378027000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Capitalization: 340095000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Debt: 9683000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 338365000.00
ORGN income_statement (annual, 2024-12-31) — Total Expenses: 100899000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 39662000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 238853000.00
ORGN balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 27113000.00
ORGN income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -84863000.00
ORGN income_statement (annual, 2024-12-31) — Total Unusual Items: -12101000.00
ORGN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -12101000.00
ORGN balance_sheet (annual, 2024-12-31) — Working Capital: 126625000.00
ORGN income_statement (annual, 2024-12-31) — Write Off: 15246000.00
ORGN income_statement (quarterly, 2025-03-31) — +Operating Expense: 16126000.00
ORGN income_statement (quarterly, 2025-03-31) — +Total Revenue: 5430000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 3176000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 19120000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -20056000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 395475000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1230000.00
ORGN cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -38000.00
ORGN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 16610000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 11282000.00
ORGN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4895077.00
ORGN income_statement (quarterly, 2025-03-31) — Basic EPS: -5.40
ORGN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 56307000.00
ORGN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -6994000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4104000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 43835000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 83048000.00
ORGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -4542000.00
ORGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 540000.00
ORGN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -8439000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 130000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 1409000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 60000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 44000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Payable: 130000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 1539000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 300000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -521000.00
ORGN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1422000.00
ORGN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -12441000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Common Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 314608000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 50453000.00
ORGN income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5317000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6922000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Assets: 119509000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 334000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Debt: 1730000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2064000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 12572000.00
ORGN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 58000.00
ORGN cash_flow (quarterly, 2025-03-31) — Deferred Tax: 58000.00
ORGN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2714000.00
ORGN income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 2714000.00
ORGN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2714000.00
ORGN income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 2714000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 1788000.00
ORGN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4895077.00
ORGN income_statement (quarterly, 2025-03-31) — Diluted EPS: -5.40
ORGN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — EBIT: -26334000.00
ORGN income_statement (quarterly, 2025-03-31) — EBITDA: -23620000.00
ORGN cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: -31000.00
ORGN cash_flow (quarterly, 2025-03-31) — End Cash Position: 43835000.00
ORGN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -4542000.00
ORGN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -15433000.00
ORGN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -2679000.00
ORGN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 3946000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -16314000.00
ORGN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 10111000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 65000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 20350000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 235061000.00
ORGN income_statement (quarterly, 2025-03-31) — Gross Profit: 113000.00
ORGN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
ORGN income_statement (quarterly, 2025-03-31) — Interest Expense: 48000.00
ORGN income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 48000.00
ORGN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 50000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Inventory: 866000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 318068000.00
ORGN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 540000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 58603000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Leases: 4765000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 3770000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1730000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 5500000.00
ORGN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: 0.00
ORGN balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 114296000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -26441000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -26441000.00
ORGN income_statement (quarterly, 2025-03-31) — Net Interest Income: -48000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 7534000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -4542000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
ORGN income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -48000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Net PPE: 215005000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -6994000.00
ORGN cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: -4542000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 314543000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 563000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 563000.00
ORGN income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -10956000.00
ORGN income_statement (quarterly, 2025-03-31) — Normalized Income: -16436440.00
ORGN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -8439000.00
ORGN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2679000.00
ORGN income_statement (quarterly, 2025-03-31) — Operating Income: -16013000.00
ORGN income_statement (quarterly, 2025-03-31) — Operating Revenue: 5430000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4983555.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2087000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1730000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 410000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -16314000.00
ORGN income_statement (quarterly, 2025-03-31) — Other Gand A: 10111000.00
ORGN income_statement (quarterly, 2025-03-31) — Other Income Expense: -10321000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 65000.00
ORGN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -2374000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 13835000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 14509000.00
ORGN income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 2343000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Properties: 6944000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3106000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 39213000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Payables: 3176000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 10098000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
ORGN income_statement (quarterly, 2025-03-31) — Pretax Income: -26382000.00
ORGN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
ORGN balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
ORGN cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
ORGN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -280000000.00
ORGN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -6994000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Raw Materials: 866000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Receivables: 22226000.00
ORGN income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5317000.00
ORGN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2714000.00
ORGN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -4542000.00
ORGN income_statement (quarterly, 2025-03-31) — Research And Development: 3301000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -64568000.00
ORGN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 287534000.00
ORGN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
ORGN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 10111000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Share Issued: 4983555.00
ORGN cash_flow (quarterly, 2025-03-31) — Short Term Debt Payments: -4542000.00
ORGN income_statement (quarterly, 2025-03-31) — Special Income Charges: -16610000.00
ORGN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2289000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 314608000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 314543000.00
ORGN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -2659440.00
ORGN income_statement (quarterly, 2025-03-31) — Tax Provision: 59000.00
ORGN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
ORGN balance_sheet (quarterly, 2025-03-31) — Total Assets: 348977000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 316338000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Debt: 7564000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 314608000.00
ORGN income_statement (quarterly, 2025-03-31) — Total Expenses: 21443000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 34369000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 229468000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 21797000.00
ORGN income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -32623000.00
ORGN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -12664000.00
ORGN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -12664000.00
ORGN balance_sheet (quarterly, 2025-03-31) — Working Capital: 106937000.00
ORGN income_statement (quarterly, 2025-03-31) — Write Off: 16610000.00
ORGN income_statement (quarterly, 2025-06-30) — +Operating Expense: 15148000.00
ORGN income_statement (quarterly, 2025-06-30) — +Total Revenue: 5813000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 2083000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 17888000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -23475000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 397812000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -1269000.00
ORGN cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -11000.00
ORGN cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
ORGN balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 9114000.00
ORGN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4927037.00
ORGN income_statement (quarterly, 2025-06-30) — Basic EPS: -2.70
ORGN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 43835000.00
ORGN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -8716000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 4025000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 35295000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 69401000.00
ORGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 57000.00
ORGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -1205000.00
ORGN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -7294000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -44000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -665000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Inventory: 178000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 23000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -53000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Payable: -44000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -709000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 254000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1637000.00
ORGN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 1330000.00
ORGN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -8442000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Common Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 311126000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 63131000.00
ORGN income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 5631000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 11351000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Assets: 101584000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 336000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Debt: 1730000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 2066000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 15941000.00
ORGN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 67000.00
ORGN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 67000.00
ORGN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2782000.00
ORGN income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 2782000.00
ORGN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2782000.00
ORGN income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 2782000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 681000.00
ORGN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4927037.00
ORGN income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.70
ORGN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — EBIT: -12596000.00
ORGN income_statement (quarterly, 2025-06-30) — EBITDA: -9814000.00
ORGN cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: -98000.00
ORGN cash_flow (quarterly, 2025-06-30) — End Cash Position: 35295000.00
ORGN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 57000.00
ORGN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -16010000.00
ORGN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -1167000.00
ORGN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2242000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -9386000.00
ORGN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 9088000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 60000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 19157000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 255900000.00
ORGN income_statement (quarterly, 2025-06-30) — Gross Profit: 182000.00
ORGN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 26000.00
ORGN income_statement (quarterly, 2025-06-30) — Interest Expense: 31000.00
ORGN income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 31000.00
ORGN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 0.00
ORGN balance_sheet (quarterly, 2025-06-30) — Inventory: 687000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 314586000.00
ORGN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -1205000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Land And Improvements: 61484000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Leases: 4767000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 3689000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 1730000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 5419000.00
ORGN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -4542000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 119534000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -12747000.00
ORGN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -12747000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Interest Income: -31000.00
ORGN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 5394000.00
ORGN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 0.00
ORGN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -4542000.00
ORGN income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -31000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Net PPE: 232425000.00
ORGN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -6599000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 311066000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 496000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 496000.00
ORGN income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -12056000.00
ORGN income_statement (quarterly, 2025-06-30) — Normalized Income: -14518180.00
ORGN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -7294000.00
ORGN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1167000.00
ORGN income_statement (quarterly, 2025-06-30) — Operating Income: -14966000.00
ORGN income_statement (quarterly, 2025-06-30) — Operating Revenue: 5813000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5005795.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 1833000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 1730000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 441000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -9386000.00
ORGN income_statement (quarterly, 2025-06-30) — Other Gand A: 9088000.00
ORGN income_statement (quarterly, 2025-06-30) — Other Income Expense: 2370000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 60000.00
ORGN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 133000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 13812000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 15210000.00
ORGN income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 128000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Properties: 6984000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2661000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 34106000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Payables: 2083000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13434000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
ORGN income_statement (quarterly, 2025-06-30) — Pretax Income: -12627000.00
ORGN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 57000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
ORGN cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 39000.00
ORGN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -375732000.00
ORGN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -8716000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Raw Materials: 687000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Receivables: 20549000.00
ORGN income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 5631000.00
ORGN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2782000.00
ORGN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 0.00
ORGN income_statement (quarterly, 2025-06-30) — Research And Development: 3278000.00
ORGN income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
ORGN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -77315000.00
ORGN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 381126000.00
ORGN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2117000.00
ORGN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9088000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Share Issued: 5005795.00
ORGN income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
ORGN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2280000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 311126000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 311066000.00
ORGN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 470820.00
ORGN income_statement (quarterly, 2025-06-30) — Tax Provision: 120000.00
ORGN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
ORGN balance_sheet (quarterly, 2025-06-30) — Total Assets: 348377000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 312856000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Debt: 7485000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 311126000.00
ORGN income_statement (quarterly, 2025-06-30) — Total Expenses: 20779000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 37251000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 246793000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 21310000.00
ORGN income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -14966000.00
ORGN income_statement (quarterly, 2025-06-30) — Total Unusual Items: 2242000.00
ORGN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 2242000.00
ORGN balance_sheet (quarterly, 2025-06-30) — Working Capital: 85643000.00
ORGN income_statement (quarterly, 2025-06-30) — Write Off: 0.00
ORGN income_statement (quarterly, 2025-09-30) — +Operating Expense: 16881000.00
ORGN income_statement (quarterly, 2025-09-30) — +Total Revenue: 4657000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1922000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 15534000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -25954000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 400253000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -520000.00
ORGN cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -43000.00
ORGN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 210000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 9125000.00
ORGN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 4978015.00
ORGN income_statement (quarterly, 2025-09-30) — Basic EPS: -3.30
ORGN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 35295000.00
ORGN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5388000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 3943000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 34061000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 54340000.00
ORGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -1534000.00
ORGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 8544000.00
ORGN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -8139000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -213000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 523000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Inventory: 53000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 77000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -132000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Payable: -213000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 310000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -423000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 2039000.00
ORGN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 1924000.00
ORGN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1129000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Common Stock: 15000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 294987000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 61270000.00
ORGN income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 4500000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 8917000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Assets: 84135000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 331000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Debt: 1730000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2061000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 13287000.00
ORGN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 86000.00
ORGN cash_flow (quarterly, 2025-09-30) — Deferred Tax: 86000.00
ORGN cash_flow (quarterly, 2025-09-30) — Depreciation: 2836000.00
ORGN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2836000.00
ORGN income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 2836000.00
ORGN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2836000.00
ORGN income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 2836000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 518000.00
ORGN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 4978015.00
ORGN income_statement (quarterly, 2025-09-30) — Diluted EPS: -3.30
ORGN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — EBIT: -16277000.00
ORGN income_statement (quarterly, 2025-09-30) — EBITDA: -13441000.00
ORGN cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -105000.00
ORGN cash_flow (quarterly, 2025-09-30) — End Cash Position: 34061000.00
ORGN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -1534000.00
ORGN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -13527000.00
ORGN cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 71000.00
ORGN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 1053000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -11584000.00
ORGN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 10717000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 51000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 16054000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 254968000.00
ORGN income_statement (quarterly, 2025-09-30) — Gross Profit: 157000.00
ORGN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
ORGN income_statement (quarterly, 2025-09-30) — Interest Expense: 27000.00
ORGN income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 27000.00
ORGN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 121000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Inventory: 635000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 296717000.00
ORGN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 8544000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Land And Improvements: 60444000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Leases: 4766000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 3612000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 3612000.00
ORGN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -1730000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 121505000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -16382000.00
ORGN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -16382000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Interest Income: -27000.00
ORGN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 13932000.00
ORGN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1730000.00
ORGN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -1730000.00
ORGN income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -27000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Net PPE: 229014000.00
ORGN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -5388000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 294936000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 410000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 410000.00
ORGN income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -14284000.00
ORGN income_statement (quarterly, 2025-09-30) — Normalized Income: -17047970.00
ORGN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -8139000.00
ORGN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 71000.00
ORGN income_statement (quarterly, 2025-09-30) — Operating Income: -16724000.00
ORGN income_statement (quarterly, 2025-09-30) — Operating Revenue: 4657000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5017768.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 2045000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 1730000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 387000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -11584000.00
ORGN income_statement (quarterly, 2025-09-30) — Other Gand A: 10717000.00
ORGN income_statement (quarterly, 2025-09-30) — Other Income Expense: 447000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 51000.00
ORGN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 394000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 13735000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 14941000.00
ORGN income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -396000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Properties: 6983000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2456000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 20279000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Payables: 1922000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 10839000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ORGN income_statement (quarterly, 2025-09-30) — Pretax Income: -16304000.00
ORGN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 196000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ORGN cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 520000.00
ORGN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -190485000.00
ORGN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -5388000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Raw Materials: 635000.00
ORGN balance_sheet (quarterly, 2025-09-30) — Receivables: 17990000.00
ORGN income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 4500000.00
ORGN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2836000.00
ORGN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -1730000.00
ORGN income_statement (quarterly, 2025-09-30) — Research And Development: 3328000.00
ORGN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
ORGN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -93697000.00
ORGN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 204417000.00
ORGN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
ORGN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 10717000.00